Strategic partnerships Potential sales opportunities exist through continued collaboration with device and diagnostic manufacturers (e.g., biosensors, point-of-care diagnostics) leveraging General Graphene's scalable CVD graphene capabilities to accelerate commercialization.

Healthcare applications Target segments include healthcare analytics, biosensors, and membranes where graphene materials can enhance sensitivity, selectivity, and capacity, supported by past partnerships with Hememics and Sapphiros to expand biosensor production.

Scale and roll-to-roll Emphasize the company’s industrial-scale roll-to-roll CVD graphene production as a differentiator for high-volume customers needing cost-effective, consistent graphene films and carbon materials.

Strategic alliances Leverage existing and announced collaborations (GrapheneDx, Sapphiros, Graphenedx) to position General Graphene as a preferred supplier for large-volume graphene needs in sensors, electronics, and membranes.

Emerging markets Propose expansion into flexible electronics, membranes, and energy storage sectors where graphene and 2D carbon materials enable performance gains, aligning with partners pursuing scalable, repeatable production.